LOXL1 promoter haplotypes are associated with exfoliation syndrome in a U.S. Caucasian population.

PURPOSE LOXL1 is a major genetic risk factor for exfoliation syndrome (ES) and exfoliation glaucoma (EG). Recent evidence documenting reversal of risk alleles for the disease-associated missense variants R141L and G153D suggests that these variants are not causative and that they may be proxies for other unknown functional LOXL1 variants. The purpose of this study was to investigate the disease association of LOXL1 variants spanning the gene region, including the 5' and 3' regulatory regions, in a U.S. Caucasian case-control sample. METHODS Twenty-five LOXL1 single-nucleotide polymorphisms (SNPs), distributed throughout the gene, were genotyped in 196 Caucasian patients with ES/EG and 201 matched controls. Genotype data were analyzed for single SNP associations, SNP interactions, and haplotype associations. RESULTS Promoter region haplotypes that included the risk alleles for rs12914489, a SNP located in the distal promoter region and independently associated with ES, and rs16958477, a SNP previously shown to affect gene transcription, were associated with increased disease risk (P=0.0008; odds ratio [OR], 2.34; 95% confidence interval [CI], 1.42-3.85) and with protective effects (P=2.3 × 10(-6); OR, 0.38; 95% CI, 0.25-0.57). Haplotypes containing rs12914489 and rs16958477 risk and protective alleles also significantly influenced the disease risk associated with missense alleles R141L and G153D. CONCLUSIONS LOXL1 promoter haplotypes were identified that are significantly associated with ES/EG in a U.S. Caucasian population. These results suggest that promoter region SNPs can influence LOXL1 gene expression, potentially causing a reduction of enzyme activity that may predispose to disease.

[1]  M. Ramsay,et al.  Major LOXL1 risk allele is reversed in exfoliation glaucoma in a black South African population , 2010, Molecular vision.

[2]  Ningli Wang,et al.  Evaluation of LOXL1 polymorphisms in exfoliation syndrome in a Chinese population , 2009, Molecular vision.

[3]  A. Thalamuthu,et al.  Association of LOXL1 polymorphisms with pseudoexfoliation in the Chinese , 2009, Molecular vision.

[4]  R. Romero,et al.  A Single Nucleotide Polymorphism in the Promoter of the LOXL1 Gene and Its Relationship to Pelvic Organ Prolapse and Preterm Premature Rupture of Membranes , 2009, Reproductive Sciences.

[5]  P. Onkamo,et al.  Association of LOXL1 gene with Finnish exfoliation syndrome patients , 2009, Journal of Human Genetics.

[6]  G. Naumann,et al.  Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients. , 2008, The American journal of pathology.

[7]  M. Tanito,et al.  LOXL1 variants in elderly Japanese patients with exfoliation syndrome/glaucoma, primary open-angle glaucoma, normal tension glaucoma, and cataract , 2008, Molecular vision.

[8]  A. Thalamuthu,et al.  Association of LOXL1 gene polymorphisms with pseudoexfoliation in the Japanese. , 2008, Investigative ophthalmology & visual science.

[9]  T. Nakazawa,et al.  Evaluation of LOXL1 polymorphisms in eyes with exfoliation glaucoma in Japanese , 2008, Molecular vision.

[10]  Z. Yamagata,et al.  Lysyl oxidase-like 1 gene polymorphisms in Japanese patients with primary open angle glaucoma and exfoliation syndrome , 2008, Molecular vision.

[11]  Yoko Ikeda,et al.  LOXL1 genetic polymorphisms are associated with exfoliation glaucoma in the Japanese population , 2008, Molecular vision.

[12]  W. Renner,et al.  Lysyl oxidase-like protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population , 2008, Molecular vision.

[13]  U. Schlötzer-Schrehardt,et al.  Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. , 2008, Investigative ophthalmology & visual science.

[14]  A. Tarkkanen,et al.  Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma , 2008, Molecular vision.

[15]  N. Yoshimura,et al.  Lysyl oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population. , 2008, American journal of ophthalmology.

[16]  Z. Tong,et al.  Genetic association of LOXL1 gene variants and exfoliation glaucoma in a Utah cohort , 2008, Cell cycle.

[17]  N. Soumittra,et al.  Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India , 2008, Molecular vision.

[18]  M. Hauser,et al.  Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma , 2008, Molecular vision.

[19]  P. Mitchell,et al.  Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people. , 2007, Human molecular genetics.

[20]  Ivana K. Kim,et al.  DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a U.S. clinic-based population with broad ethnic diversity , 2008, BMC Medical Genetics.

[21]  C. Lindén,et al.  Incidence and prevalence of pseudoexfoliation and open-angle glaucoma in northern Sweden: I. Baseline report. , 2007, Acta ophthalmologica Scandinavica.

[22]  Young H. Kwon,et al.  LOXL1 mutations are associated with exfoliation syndrome in patients from the midwestern United States. , 2007, American journal of ophthalmology.

[23]  F. Jónasson,et al.  Pseudoexfoliation in the Reykjavik Eye Study: prevalence and related ophthalmological variables. , 2007, Acta ophthalmologica Scandinavica.

[24]  Kari Stefansson,et al.  Common Sequence Variants in the LOXL1 Gene Confer Susceptibility to Exfoliation Glaucoma , 2007, Science.

[25]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[26]  A. Lu,et al.  Exfoliation syndrome: prevalence and inheritance in a subisolate of the Finnish population. , 2007, Acta ophthalmologica Scandinavica.

[27]  D. Hodge,et al.  The Risk of Glaucoma in Pseudoexfoliation Syndrome , 2007, Journal of glaucoma.

[28]  H. Quigley,et al.  The number of people with glaucoma worldwide in 2010 and 2020 , 2006, British Journal of Ophthalmology.

[29]  Y. Nose,et al.  The Prevalence of Pseudoexfoliation Syndrome in a Japanese Population: The Hisayama Study , 2005, Journal of glaucoma.

[30]  P. Nirmalan,et al.  Pseudoexfoliation in southern India: the Andhra Pradesh Eye Disease Study. , 2005, Investigative ophthalmology & visual science.

[31]  P. Foster,et al.  The prevalence of pseudoexfoliation syndrome in Chinese people: the Tanjong Pagar Survey , 2005, British Journal of Ophthalmology.

[32]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[33]  Jiangang Gao,et al.  Elastic fiber homeostasis requires lysyl oxidase–like 1 protein , 2004, Nature Genetics.

[34]  H. Taylor,et al.  Pseudoexfoliation syndrome in Australian adults. , 2000, American journal of ophthalmology.

[35]  H. Quigley.  Number of people with glaucoma worldwide. , 1996, The British journal of ophthalmology.

[36]  S. F. Ball.  EXFOLIATION SYNDROME PREVALENCE IN THE GLAUCOMA POPULATION OF SOUTH LOUISIANA , 1988, Acta ophthalmologica. Supplement.

[37]  M. B. Shields,et al.  Exfoliation syndrome. Prevalence in a southeastern United States population. , 1988, Archives of ophthalmology.

[38]  D. E. Krueger,et al.  Pseudoexfoliation, intraocular pressure, and senile lens changes in a population-based survey. , 1982, Archives of ophthalmology.

[39]  H. Aasved.  THE GEOGRAPHICAL DISTRIBUTION OF FIBRILLOPATHIA EPITHELIOCAPSULARIS , 1969, Acta ophthalmologica.